Street smarts: SBA Disaster Assitance deadline approaching for Mountain Fire survivors
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Fearless Femme Summit brings together women in STEM
According to the National Center for Science and Engineering Statistics, the share of women in the Science, Technology, Engineering, and Mathematics (STEM) workforce has grown exponentially over the last decade. Between 2011 and 2021, the number of women in STEM increased by 31%, from 9.4 million to 12.3 million, with women accounting for 35% of Read More →
CRE: Atascadero Planning Commission approves new RV resort to boost tourism
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Capsida receives $40M from Abbie collaboration
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
PBS Biotech secures $17 million in follow-on round
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
A2 Bio closes $80 million Series C financing round
Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a syndicate of investors that includes The Column Group and Samsara BioCapital. A2 Bio is developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells. Proceeds Read More →
Housing remains the biggest tri-county issue in 2025
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
